The investigation of SMAD family member 7 (Smad7) ASOs as a potential treatment for inflammatory bowel disease by inhibition of transforming growth factor-β1, which plays a role in mucosal inflammation in the gut, Smad7 ASOs were found safe and tolerable by patients with Crohn’s disease [65]. The gene discussed is SMAD7; the disease is inflammatory bowel disease.